학술논문
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Document Type
Artikel
Author
Bellini, A; Potschger, U; Bernard, V; Lapouble, E; Baulande, S; Ambros, PF; Auger, N; Beiske, K; Bernkopf, M; Betts, DR; Bhalshankar, J; Bown, N; de Preter, K; Clement, N; Combaret, V; de Mora, JF; George, SL; Jimenez, I; Jeison, M; Marques, B; Martinsson, T; Mazzocco, K; Morini, M; Muhlethaler-Mottet, A; Noguera, R; Pierron, G; Rossing, M; Taschner-Mandl, S; Van Roy, N; Vicha, A; Chesler, L; Balwierz, W; Castel, V; Elliott, M; Kogner, P; Laureys, G; Luksch, R; Malis, J; Popovic-Beck, M; Ash, S; Delattre, O; Valteau-Couanet, D; Tweddle, DA; Ladenstein, R; Schleiermacher, G
Source
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(30):3377
Subject
Language
English
English
English
ISSN
1527-7755